Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2243 (LINC02243) is a human gene transcribed into a long intergenic non-coding RNA, which does not overlap with coding genes and does not code for a protein. LincRNAs such as LINC02243 are part of a class of RNA molecules longer than 200 nucleotides with diverse regulatory roles in the cell, including chromatin remodeling, transcription regulation, RNA stabilization, and context-dependent modulation of neighboring gene expression. LINC02243 is recognized as a unique non-coding RNA transcript, but as of current evidence, its direct implication as a therapeutic target or disease biomarker, as well as any drug interactions, has not been established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2243 (LINC02243).